UNUM THERAPEUTICS INC.

Profile

Company Names

UNUM THERAPEUTICS INC.
UNUM THERAPEUTICS, INC.

Addresses

200 CAMBRIDGE PARK DRIVE, SUITE 3100, CAMBRIDGE, MA 02140

ONE BROADWAY, 4TH FLOOR, CAMBRIDGE, MA 02142

Phone Numbers

617-945-5576
1-617-863-3679

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER HEALTH CARE

Year Incorporated:

2014

State Incorporated:

DELAWARE

Total Amount Raised:

$220,464,839.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2020-07-09 
$104,400,000.00 
$104,400,000.00 
$0.00 
Equity 
3
2020-07-06 
$44,812,154.00 
$44,812,154.00 
$0.00 
Equity 
2
2015-06-10 
$65,000,000.00 
$65,000,000.00 
$0.00 
Equity 
1
2014-10-03 
$6,252,685.00 
$12,252,685.00 
$6,000,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
BEN 
 
AUSPITZ 
DIRECTOR
LIGOCYTE PHARMACEUTICALS INC   |  ULTRAGENYX PHARMACEUTICAL INC.   |  SYMBIOMIX THERAPEUTICS, LLC   |  UNUM THERAPEUTICS, INC.   |  PRECISION BIOSCIENCES INC   |  COMPASS THERAPEUTICS LLC   |  CHECKMATE PHARMACEUTICALS, INC.   |  INDALO THERAPEUTICS, INC.   |  MEVES PHARMACEUTICALS, INC.   |  ZERO POINT FIVE THERAPEUTICS, INC.   |  ANTLIA BIOSCIENCE, INC.
BRUCE 
 
BOOTH 
DIRECTOR
MIRAGEN THERAPEUTICS INC   |  AVILA THERAPEUTICS INC   |  ZAFGEN, INC.   |  NIMBUS DISCOVERY, LLC   |  ON-Q-ITY, INC.   |  NUMERATE INC   |  UNUM THERAPEUTICS, INC.   |  LYSOSOMAL THERAPEUTICS, INC.   |  AVROBIO, INC.   |  MAGENTA THERAPEUTICS, INC.   |  ATLAS VENTURE FUND XI, L.P.   |  RODIN THERAPEUTICS, INC.   |  ATLAS VENTURE OPPORTUNITY FUND I, L.P.   |  ATLAS VENTURE FUND XII, L.P.   |  VIGIL NEUROSCIENCE, INC.   |  ATLAS VENTURE OPPORTUNITY FUND II, L.P.   |  ATLAS VENTURE FUND XIII, L.P.   |  MATCHPOINT THERAPEUTICS INC.   |  ATLAS VENTURE FUND XIV, L.P.   |  ATLAS VENTURE OPPORTUNITY FUND ILL, L.P.
CHRIS 
 
CAIN 
DIRECTOR
UNUM THERAPEUTICS INC.
KAREN 
 
FERRANTE 
DIRECTOR
UNUM THERAPEUTICS INC.
JOHN 
L. 
GREEN 
EXECUTIVE OFFICER
UNUM THERAPEUTICS INC.
PETER 
 
HARWIN 
DIRECTOR
FAIRMOUNT HEALTHCARE FEEDER FUND LTD.   |  FAIRMOUNT HEALTHCARE FUND L.P.   |  QUELLIS BIOSCIENCES, INC.   |  VIRIDIAN, LLC   |  FAIRMOUNT HEALTHCARE FEEDER FUND II LTD.   |  FAIRMOUNT HEALTHCARE FUND II L.P.   |  VIRIDIAN THERAPEUTICS, INC.   |  UNUM THERAPEUTICS INC.   |  PARAGON THERAPEUTICS, INC.   |  FAIRMOUNT HEALTHCARE CO-INVEST L.P.   |  AEGLEA BIOTHERAPEUTICS, INC.   |  FAIRMOUNT HEALTHCARE FEEDER FUND II L.P.   |  FAIRMOUNT HEALTHCARE CO-INVEST II L.P.   |  SPYRE THERAPEUTICS, INC.   |  GALECTO, INC.
ARLENE 
 
MORRIS 
DIRECTOR
AFFYMAX INC   |  NUON THERAPEUTICS INC   |  SYNDAX PHARMACEUTICALS INC   |  VIVEVE MEDICAL, INC.   |  UNUM THERAPEUTICS INC.   |  TC BIOPHARM (HOLDINGS) PLC
LIAM 
 
RATCLIFFE 
DIRECTOR
AFFERENT PHARMACEUTICALS, INC.   |  NEURONETICS, INC.   |  UNUM THERAPEUTICS, INC.   |  ARVINAS HOLDING COMPANY, LLC   |  NEW LEAF GROWTH FUND I, L.P.   |  APTINYX INC.   |  CURASEN THERAPEUTICS, INC.   |  ARVINAS, INC.   |  ELIEM THERAPEUTICS, INC.   |  HALDA THERAPEUTICS, LLC
MATTHEW 
 
ROS 
DIRECTOR
UNUM THERAPEUTICS INC.   |  FORE US BIO INC.
JESSICA 
 
SACHS 
EXECUTIVE OFFICER
UNUM THERAPEUTICS INC.
CHRISTIANA 
 
STAMOULIS 
EXECUTIVE OFFICER
UNUM THERAPEUTICS, INC.
CHARLES 
 
WILSON 
EXECUTIVE OFFICER, DIRECTOR
ETOUCHES, INC.   |  UNUM THERAPEUTICS, INC.   |  BELLROCK INTELLIGENCE, INC.   |  CUMBERLAND COUNTY INDUSTRIAL DEVELOPMENT AUTHORITY   |  UNUM THERAPEUTICS INC.   |  IMMERSIONED INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-07-21
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-07-06 
2020-07-21
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-07-09 
2015-06-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-06-10 
2014-10-20
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2014-10-03 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#